MAGNETOM Vida; MAGNETOM Lumina; MAGNETOM Aera; MAGNETOM Skyra; MAGNETOM Prisma; MAGNETOM Prisma fit
Siemens Medical Solutions USA, Inc. • Radiology • 10/23/2023
Device Purpose
The MAGNETOM MRI systems are designed for comprehensive diagnostic imaging of the head, body, and extremities, producing various image types and spectra to assist physicians in diagnosis, and can support MR-guided interventional procedures. These systems are updated with syngo MR XA60A software and hardware modifications, introducing new functionalities like Deep Resolve Boost, Open Recon, and MR Fingerprinting to enhance imaging capabilities and diagnostic information.
Summary
The MAGNETOM systems (Vida, Lumina, Aera, Skyra, Prisma, Prisma fit) are magnetic resonance diagnostic devices (MRDD) designed to produce a variety of images including transverse, sagittal, coronal, and oblique cross-sections, as well as spectroscopic images and spectra. These systems display the internal structure and function of the head, body, or extremities, and can derive other physical parameters from the acquired data. Contrast agents may be used depending on the region of interest, and the resulting information, when interpreted by a trained physician, aids in diagnosis. The MAGNETOM systems are also indicated for imaging during interventional procedures when used with MR-compatible devices like in-room displays and MR Safe biopsy needles. This submission details updates to these MAGNETOM models, primarily through the introduction of the syngo MR XA60A software and various hardware modifications. Key hardware changes include updated host computers (syngo MR Acquisition Workplace and syngo MR Workplace) and Measurement and Reconstruction Systems (MaRS) for several models, and a new Flex Loop Large coil for MAGNETOM Aera. New software features and applications common to many models include GRE_PC, Physio logging, Open Recon, and MR Fingerprinting (previously cleared). Specific models like Vida and Lumina also receive Deep Resolve Boost HASTE and Deep Resolve Boost EPI Diffusion. Modified features include the renaming of BEAT_nav, updates to myExam Angio Advanced Assist (Test Bolus), and modifications to the Beat Sensor for all sequences on certain models. Non-clinical testing, including software verification and validation, image quality assessments, and AI feature training, was performed to support the changes.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How do the 'Deep Resolve Boost' algorithms for HASTE and EPI Diffusion specifically improve image quality metrics (e.g., SNR, CNR, artifact reduction) or reduce scan times compared to conventional reconstruction methods?; What are the specific advantages and potential limitations of the 'Open Recon' feature for researchers or clinicians aiming to implement custom reconstruction algorithms?; For the 'MR Fingerprinting' feature, what are the validated ranges of T1 and T2 values it can accurately quantify, and how does its performance compare across different field strengths (1.5T and 3T)?; What are the specific performance improvements (e.g., SNR, coverage) offered by the new 'Flex Loop Large coil' for the MAGNETOM Aera, and for which anatomical regions is it optimized?; How does the 'Physio logging' feature integrate with image acquisition, and what specific physiological parameters can be recorded and correlated with imaging data for enhanced diagnostic information or research?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, HBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Not detected in AI-generated device summary: SBOM, SaaSBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly